By Paul Murray, CEO, Swiss Re Life & Health Reinsurance
![](https://magazine.cover.co.za/wp-content/uploads/2025/01/Paul-Murray-Swiss-Re-No-logo.jpg)
Forecasting the future can be a notoriously tricky business, for reinsurers or anyone else.
Diligent, data-driven forecasting helps us set expectations, guide decision-making, identify risks and opportunities – and provides a compass to recalibrate, should things develop differently than anticipated. There’s always that tension between the actual versus the expected.
Here are a few thoughts on what life and health insurance and reinsurance themes I believe will be important in 2025.
Steady growth, strong profitability
After the Global Financial Crisis more than a decade ago prompted central banks to cut interest rates, it felt to many of us on the life insurance side of our industry that ultra-loose monetary policy would never end. When the pendulum finally swung back as inflation surged during the COVID-19 pandemic, insurers began benefiting from higher fixed-income returns. Annuity products with attractive rates have seen unprecedented demand.
In my view, life insurers will continue to see steady growth in 2025 – perhaps not the decade-high levels of last year, but still exceeding the historical average. One change we will likely see over time is a shift from fixed-rate annuities toward indexed products, not only in countries like Italy and France where demand is already strong but also in the US as normalising monetary policy supports a pivot among clients. With fixed income yields still robust, life insurers’ 2025 profitability prospects are intact.
![](https://magazine.cover.co.za/wp-content/uploads/2024/11/Curate-A-good-curator-selects-only-the-best.jpg)
A good curator selects only the best.
At Curate, we handpick the best people to look after your money.
That is the art of investing.
Curate Investments (Pty) Ltd is an authorised financial services provider (FSP No. 53549). Registration number 2023/747232/07.
Partnering to de-risk pensions
With higher interest rates also helping shore up defined-benefit pension funding, the pace of de-risking transactions like bulk annuity transfers is likely to continue and may even accelerate in 2025. Part of this relates to demographic change, with Baby Boomers who have either retired or planning to retire; globally, people older than 60 years outnumber those under five. Consequently, pension funds are looking to protect themselves from potential longevity risks accompanying the aging populations they protect.
UK Solvency II reforms should drive additional pension risk-transfer activity, creating new opportunities for reinsurers to assist clients. And with many life insurers assessing the impact of their transitions to IFRS accounting standards, I see expanded scope for reinsurance to help them optimise their balance sheets and fuel new business growth.
A year to turn the corner?
Looking at mortality improvement trends closely has raised concerns about plateauing longevity gains, as factors like rising rates of obesity and diabetes conspired to slow progress in key insurance markets even before COVID-19 hit. And while the pandemic has passed its acute phase, we are still living with its consequences. COVID-related excess mortality in the general population could be up to 3% higher than pre-pandemic levels in the US and 2.5% higher in the UK by 2033.
However, under more optimistic scenarios, in which healthcare systems succeed in reducing lingering pandemic backlogs, mortality could return to pre-pandemic levels more quickly. Disease prevention, including vaccinations and a strong emphasis on healthier lifestyles to counteract chronic metabolic disease and cancer, will help. And while it’s early days, GLP-1 drugs also offer great potential to improve health outcomes.
I personally am cautiously optimistic that 2025 could be the year in which we start turning the corner on reinvigorating mortality improvement.
For 2025, I also believe the pandemic’s lingering shadow will fuel increased awareness of infectious disease as a potential threat. We have seen signs of this already.
Last August, the World Health Organization (WHO) issued a health warning about the spread of Mpox. We have also seen renewed attention on antimicrobial resistance, which could kill millions more people annually by mid-century. This heightened vigilance is a good thing, helping detect threats such as the current bird flu outbreak so they can be effectively contained.
Forecasting the future – and shaping it
Insurers and reinsurers must work proactively to harness the forces transforming our industry, this year and any other year. But the challenge lies not just in forecasting the future but shaping it.
For 2025, this means putting attractive market conditions to work to support retirement savings products and industry profitability; recognising opportunities that accompany changing demographics and regulatory developments; and staying watchful for threats to public health that only a few years ago might have seemed remote.